Retraction

TRIM44 Promotes Endometrial Carcinoma Progression by Activating the FRS2 Signalling Pathway

Citations (3)

3
Total Citations
1
Post-Retraction
(33.3%)
1
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
1 Within 30 days
1 Within 1 year
0 After 2+ years
2 Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
TMEM41A overexpression correlates with poor prognosis and immune alterations in patients with endometrial carcinoma
Ke Shi, Xiaoli Liu, Qiang Guo et al. (8 authors)
PLoS ONE Open Access
Published: Jul 2023
2 citations
2 days after retraction
Retracted: TRIM44 Promotes Endometrial Carcinoma Progression by Activating the FRS2 Signalling Pathway
Evidence-Based Complementary and Alternative Medicine
Evidence-based Complementary and Alternative Medicine Open Access
Published: Jan 2023
199 days before retraction
Quick Stats
Total Citations: 4
Years Since Retraction: 2.3 years
Open Access: Yes
Last Checked: Jul 24, 2025
Related Papers
Synergistic Effect of Zuo Jin Wan on DDP-Induced Apoptosis …
Evidence-Based Complementary and Alternative Medicine • 13 citations
TGF-β signaling proteins and CYP24A1 may serve as surrogate…
Translational Cancer Research • 10 citations
Citrus Genus and Its Waste Utilization: A Review on Health-…
Evidence-Based Complementary and Alternative Medicine • 94 citations
The Therapeutic Potential of Wogonin Observed in Preclinica…
Evidence-Based Complementary and Alternative Medicine • 47 citations
Noscapine, an Emerging Medication for Different Diseases: A…
Evidence-Based Complementary and Alternative Medicine • 47 citations